Stop Alzheimer’s before it starts

Two new drugs being studied at Wash U study could help Alzheimer’s patients

The fight against Alzheimer’s: ‘Every Minute Counts’ reveals latest developments

Alzheimer’s disease affects more than 5 million Americans. Neurologist Dr. Rudy Tanzi and Daisy Duarte, whose mother is in the final stages of Alzheimer’s, talk to Kathie Lee Gifford and Jenna Bush Hager about the new PBS documentary “Every Minute Counts,” which reveals the latest developments in the fight against the devastating illness.

The New Offensive on Alzheimer’s disease: Stop it before it Starts

Alzheimer’s-Every Minute Counts

WashU early AD initiative could yield broader clues

If intervening ahead of symptoms in Alzheimer’s disease (AD) works in people with gene mutations that predispose them to getting sick at a younger age, then it will probably work in the rest of the population, principal investigator Randall Bateman theorized to BioWorld Today, and his team at Washington University (WashU) – testing drugs provided by big pharma – hopes to prove as much.

Early Alzheimer’s Gene Is A Curse For Families, A Gift For Science

The Alzheimer’s Laboratory

Eli Lilly’s Experimental Alzheimer’s Drug Fails in Large Trial

An experimental Alzheimer’s drug that had previously appeared to show promise in slowing the deterioration of thinking and memory has failed in a large Eli Lilly clinical trial, dealing a significant disappointment to patients hoping for a treatment that would alleviate their symptoms.

Dominantly Inherited Alzheimer Network Trial (DIAN-TU-001) continues despite results from Eli Lilly and Company’s EXPEDITION3 trial